chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Visual impairment
Clinical narrative: Diplopia (Double Vision) I had severe headache and neck pain on Wednesday, July 27 2022 around 3:00 pm which I expected. However, I started feeling unusual vision on July 28 and 29. On July 30th morning I started seeing distance diplopia. Dr. advised me t rush to Hospital. I was tested for EKG, CT Scan, and MRI on July 30 and 31 suspecting a stroke but I was cleared and sent home. On Wednesday August I was seen by Dr. He also confirmed diplopia. My headache persisted till Saturday August 13,2022 My diplopia continues till the time of this report.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 67.0
Sex: M
Vaccine: HEPAB
Symptoms: Expired product administered, No adverse event
Clinical narrative: Administration of expired vaccine. Expiration date: 8/7/22. Administration date: 8/16/22. No adverse symptoms reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Pyrexia
Clinical narrative: fatigue, fever, weakness
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness, Malaise
Clinical narrative: patient did not feel well 2 minutes after vaccine and started to lose consciousness.  Called 911 and administered 1 dose of epipen 0.3mg's.  Was feeling better after the epipen, however we do not think it was an allergic reaction
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: vaccinated, covid positive pt, hospitalization
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache
Clinical narrative: fatigue, weakness, headaches
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Confusional state, Dyspnoea, SARS-CoV-2 test positive, Somnolence
Clinical narrative: 8/13- more somnolent, and SOB as well as confused. Tested positive for covid 8/14/22. Treatment includes potential paxlovid, albuterol, assessment, oxygen.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pfizer stored in regular freezer for longer than 2 weeks and patient received.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Nasopharyngitis, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19 on 08/12/2022  I had  mild cold symptoms like cough; head cold; runny nose.  I did a tele health   as soon as I tested positive.  She prescribed me PAXLOVID for 5 days.  I have to isolate for 10 days and am still recovering as of now.
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, Asthenia, COVID-19, Fatigue, Hypoxia
Clinical narrative: Patient brought to the ED via EMS on 7/15 for weakness, fever, and fatigue. While in the ED, he became hypoxic to about 84% and was placed on oxygen by NC. COVID-19 PCR swab in the ED was positive. Patient was admitted for further COVID related cares given his hypoxia, and was admitted 7/15-7/18. He was diagnosed with acute hypoxic respiratory failure due to COVID-19. He is vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient brought to the ED via EMS on 7/15 for weakness, fever, and fatigue. While in the ED, he became hypoxic to about 84% and was placed on oxygen by NC. COVID-19 PCR swab in the ED was positive. Patient was admitted for further COVID related cares given his hypoxia, and was admitted 7/15-7/18. He was diagnosed with acute hypoxic respiratory failure due to COVID-19. He is vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Fatigue, headache, muscle aches, fever for approximately 24 hours.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Admitted to the hospital with COVID-19.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Myalgia
Clinical narrative: SOB, chest pain, myalgias
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case COVID-19 after fully vaccinated (2 doses mRNA).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare facility consulted with the regulatory authority and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare facility is working with the regulatory authority on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 69.0
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Agency consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working with the DPHE on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Lethargy, Paranasal sinus hypersecretion, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Slight fever, sinus drainage, lethargy. Symptoms noticed on return travel.  Temperature normal within 2 days. Symptoms largely gone within 2 weeks.
Age: 30.0
Sex: M
Vaccine: UNK
Symptoms: Injection site cellulitis, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Pain , Swelling, redness at injection site (cellulitis)
Age: 85.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Admitted to hospital with COVID-19
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Moderna COVID-19 vaccine booster dose #4 administered in full dose (0.5mL) by error. No adverse event reported.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the local health dept on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product administration error
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product administration error
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the local health dept. on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Admitted to the hospital with COVID-19.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. consulted with the Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working  on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working  on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory distress syndrome, Acute respiratory failure, Asthenia, COVID-19, Death
Clinical narrative: Patient presented to hospital on 01/09/2022 with weakness and was obtunded.  Patient was found to be hypotensive and was treated for acute hypoxic/hypercapnic respiratory failure secondary to COVID 19 with PNA and subsequently had ARDS.  Patient did required ventilator support and family did decide on comfort care and was extubated.  Patient expired on 02/12/2022.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Depressed level of consciousness, Endotracheal intubation, Hypotension, Mechanical ventilation, Pneumonia
Clinical narrative: Patient presented to hospital on 01/09/2022 with weakness and was obtunded.  Patient was found to be hypotensive and was treated for acute hypoxic/hypercapnic respiratory failure secondary to COVID 19 with PNA and subsequently had ARDS.  Patient did required ventilator support and family did decide on comfort care and was extubated.  Patient expired on 02/12/2022.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure
Clinical narrative: Patient presented to hospital on 01/09/2022 with weakness and was obtunded.  Patient was found to be hypotensive and was treated for acute hypoxic/hypercapnic respiratory failure secondary to COVID 19 with PNA and subsequently had ARDS.  Patient did required ventilator support and family did decide on comfort care and was extubated.  Patient expired on 02/12/2022.
Age: 18.0
Sex: F
Vaccine: TDAP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Given earlier than indicated
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare facility consulted with the regulatory authority and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare facility is working with the regulatory authority on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC20, RV5
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient did not have any adverse event to vaccine, we were told to fill out form due to receiving Prevnar 20 instead of Prevnar 13.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Blood test, Cerebrovascular accident, Coma, Computerised tomogram
Clinical narrative: First shot, the arm was sore and she had a headache for a few days. The second shot totally messed up her monthly cycles along with more headaches. Months later had a massive pulmonary embolism which resulted in a thoracotomy.  She came out of the OR on ECMO and Life Support. Was in a coma for 5 days. During this time she had a right frontal lobe stroke with subsequent seizures. She now takes blood thinners and two types of seizure medication. All genetic testing for clotting issues have been negative.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Electroencephalogram, Headache, Laboratory test normal, Life support
Clinical narrative: First shot, the arm was sore and she had a headache for a few days. The second shot totally messed up her monthly cycles along with more headaches. Months later had a massive pulmonary embolism which resulted in a thoracotomy.  She came out of the OR on ECMO and Life Support. Was in a coma for 5 days. During this time she had a right frontal lobe stroke with subsequent seizures. She now takes blood thinners and two types of seizure medication. All genetic testing for clotting issues have been negative.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Lung assist device therapy, Magnetic resonance imaging, Menstrual disorder, Pain in extremity, Pulmonary embolism
Clinical narrative: First shot, the arm was sore and she had a headache for a few days. The second shot totally messed up her monthly cycles along with more headaches. Months later had a massive pulmonary embolism which resulted in a thoracotomy.  She came out of the OR on ECMO and Life Support. Was in a coma for 5 days. During this time she had a right frontal lobe stroke with subsequent seizures. She now takes blood thinners and two types of seizure medication. All genetic testing for clotting issues have been negative.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Seizure, Thoracotomy
Clinical narrative: First shot, the arm was sore and she had a headache for a few days. The second shot totally messed up her monthly cycles along with more headaches. Months later had a massive pulmonary embolism which resulted in a thoracotomy.  She came out of the OR on ECMO and Life Support. Was in a coma for 5 days. During this time she had a right frontal lobe stroke with subsequent seizures. She now takes blood thinners and two types of seizure medication. All genetic testing for clotting issues have been negative.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The vaccine in question expired August 10, 2022 and was administered on Aug 13, 2022 by Rph.  Manufacturer was contaced and we were given this response: ?Analysis of the vials associated with your storage excursion is complete. The vaccine administered on August 13, 2022 from lot number AR4504B maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.?
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working with the Dept of Public Health and Environment on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare office consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alcohol withdrawal syndrome, Anal incontinence, Confusional state, Hypovolaemia, Interchange of vaccine products
Clinical narrative: 7/15/2022 patient presented to ER after children found her at home on the couch covered in feces. Admitted to the hospital for confusion, rhabdomyolysis, hypovelemia, and alcohol withdrawal.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rhabdomyolysis
Clinical narrative: 7/15/2022 patient presented to ER after children found her at home on the couch covered in feces. Admitted to the hospital for confusion, rhabdomyolysis, hypovelemia, and alcohol withdrawal.
Age: 28.0
Sex: F
Vaccine: RAB
Symptoms: Urticaria
Clinical narrative: Patient stated that she had hives 20 minutes after receiving  the vaccine. She proceeded to take a antihistamine (zyrtec) and the hives went away. Patient stated she was feeling okay after about an hour.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Admitted to the hospital with COVID-19
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, COVID-19, Feeling abnormal, SARS-CoV-2 test positive
Clinical narrative: 05/16/2022 I had vaccination. On 07/16/2022 I was traveling that evening. I drove home from feeling a little out of sorts. On 07/17/2022 my temperature was 102. 07/18/2022 I took a COVID-19 at home test and it was positive. On 07/19/2022 I sought medical attention and was prescribed Plaxovid. I started the medication that evening and for the 5 day period. I am feeling reasonably good presently.
Age: 43.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Muscle pain below injection site, warm, swollen for > 1 week.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Moderna COVID-19 vaccine booster dose #4 administered in full dose (0.5mL) by error. No adverse event reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered vaccination one day passed the Beyond Use Date expiration
Age: 32.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: About 3 hours after the vaccination was administered I felt a stinging pain at the vaccination site on my left back arm. Since then, the vaccination site has had this stinging pain. It feels like I was stung by a bee. The vaccination site has a slight bump and looks like there is a straight cut going right throught the middle of it. The top of the bump looks like a boil that bursted. I have received the vaccination 48 hours ago and although the symptoms have not worsened, it has remained static. A stinging pain in my arm. I have kept the site clean and continue to apply neosporin.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID-19 on 8/7/2022.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Joint injury, Laboratory test
Clinical narrative: Felt like "rubber band snapped" at her ankle. Being evaluated for tendonitis or rupture
Age: 10.0
Sex: M
Vaccine: COVID19, MNQ, TDAP
Symptoms: Product preparation error
Clinical narrative: Vaccine was diluted with sterile water instead of sodium chloride, and administered to the patient.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare facility consulted with the regulatory authority and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare facility is working with the regulatory authority on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 27.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Body temperature increased, COVID-19, Coordination abnormal, Cough
Clinical narrative: I had no problem with the vaccination, but did test positive for Covid-19 just over three months later (4/27/2022). I started Paxlovid the same day I tested positive with the breakthrough infection and then unfortunately had a rebound infection starting 5/4/2022. I finally tested negative again on 5/13/2022.  My initial symptoms were loss of voice, sore throat, cough, sneezing, congestion, minor fever/elevated temp, headache, dizziness, fatigue, loss of coordination, nausea, swollen glands. Once Paxlovid kicked in I had a horrible bitter/metallic taste in my mouth (dysgeusia). I had debilitating fatigue for about a month after infection. It took me ~6 weeks to feel like I was recovered from Covid.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Lymphadenopathy, Nausea
Clinical narrative: I had no problem with the vaccination, but did test positive for Covid-19 just over three months later (4/27/2022). I started Paxlovid the same day I tested positive with the breakthrough infection and then unfortunately had a rebound infection starting 5/4/2022. I finally tested negative again on 5/13/2022.  My initial symptoms were loss of voice, sore throat, cough, sneezing, congestion, minor fever/elevated temp, headache, dizziness, fatigue, loss of coordination, nausea, swollen glands. Once Paxlovid kicked in I had a horrible bitter/metallic taste in my mouth (dysgeusia). I had debilitating fatigue for about a month after infection. It took me ~6 weeks to feel like I was recovered from Covid.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, Rebound effect, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I had no problem with the vaccination, but did test positive for Covid-19 just over three months later (4/27/2022). I started Paxlovid the same day I tested positive with the breakthrough infection and then unfortunately had a rebound infection starting 5/4/2022. I finally tested negative again on 5/13/2022.  My initial symptoms were loss of voice, sore throat, cough, sneezing, congestion, minor fever/elevated temp, headache, dizziness, fatigue, loss of coordination, nausea, swollen glands. Once Paxlovid kicked in I had a horrible bitter/metallic taste in my mouth (dysgeusia). I had debilitating fatigue for about a month after infection. It took me ~6 weeks to feel like I was recovered from Covid.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Sneezing, Vaccine breakthrough infection
Clinical narrative: I had no problem with the vaccination, but did test positive for Covid-19 just over three months later (4/27/2022). I started Paxlovid the same day I tested positive with the breakthrough infection and then unfortunately had a rebound infection starting 5/4/2022. I finally tested negative again on 5/13/2022.  My initial symptoms were loss of voice, sore throat, cough, sneezing, congestion, minor fever/elevated temp, headache, dizziness, fatigue, loss of coordination, nausea, swollen glands. Once Paxlovid kicked in I had a horrible bitter/metallic taste in my mouth (dysgeusia). I had debilitating fatigue for about a month after infection. It took me ~6 weeks to feel like I was recovered from Covid.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the local health dept. on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Heart rate irregular
Clinical narrative: The day after the vaccine could feel thumping in my chest that didn't feel right. Moved around and it got worse. Have a monitor and it showed that my BP was normal but my heartbeat was irregular. Continued to monitor BP for a couple of hours and it continued to show irregular heart beat. Now I sporadically continue to have irregular heartbeats. Already had appt with my PCP for an unrelated situation, so I told my Dr. then. Dr. said that it may be an effect of the vaccine he wasn't sure. Said if it continues to come back and I'll be placed on a heart monitor. Dr. didn't perform any testing.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Myalgia, Nausea
Clinical narrative: extreme muscle pains on the first night prior to vaccination and extreme nausea when trying to eat that has lasted for, right now, 2 weeks. an inability to eat much now because of the nausea induced.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Cystitis, Laboratory test, Loss of personal independence in daily activities, Renal cyst, Renal pain
Clinical narrative: On 07/07/2022 I started to experience, I had sharp pain on my kidney. I can't sit up. I can't do anything. On 07/14/2022 I thought I pulled a muscle and I thought I had kidney stone. 07/27/2022 I was diagnosed with bladder infection. She prescribed me antibiotics for 10 days. On 08/03/2022 the bacteria was gone but the sharp pain was getting worse. She ordered an ultrasound because she thought it was a kidney stone. She ordered some labs to see if it was a kidney stone or not. I went back on 08/12/2022 and on left side of my kidney there was a kidney cyst size 3.5 centimeters. On 08/18/2022 am going back to my doctor to see what should be done with my cyst. I will find out if I any procedure needs to be done.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Sitting disability, Ultrasound kidney abnormal, Urine analysis
Clinical narrative: On 07/07/2022 I started to experience, I had sharp pain on my kidney. I can't sit up. I can't do anything. On 07/14/2022 I thought I pulled a muscle and I thought I had kidney stone. 07/27/2022 I was diagnosed with bladder infection. She prescribed me antibiotics for 10 days. On 08/03/2022 the bacteria was gone but the sharp pain was getting worse. She ordered an ultrasound because she thought it was a kidney stone. She ordered some labs to see if it was a kidney stone or not. I went back on 08/12/2022 and on left side of my kidney there was a kidney cyst size 3.5 centimeters. On 08/18/2022 am going back to my doctor to see what should be done with my cyst. I will find out if I any procedure needs to be done.
Age: 2.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect dose administered
Clinical narrative: Technician administered 5-12 year pfizer to 2 year old @ 1500 on 16 August 2022
Age: 51.0
Sex: M
Vaccine: COVID19, VARZOS
Symptoms: Illness
Clinical narrative: Patient was ill after receiving Shingrix and COVID-19 shots. Symptoms unknown.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Extra dose administered, No adverse event
Clinical narrative: No adverse event. 23-year-old patient (pregnant) with asthma received a 2nd booster of Moderna.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal chest pain, Pain, Pain in extremity
Clinical narrative: 41-year-old male with no previous medical history presenting emergency department complaining of right-sided rib and arm pain X 1 day. Per patient, he just had his second booster shot of the Moderna vaccine, since he has been experiencing symptoms. Symptoms described as moderate in nature, better with nothing, worse with movement and touch.  No history of the same. At this time he denies any recent injury or rash to area.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare facility consulted with the regulatory authority and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare facility is working with the regulatory authority on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 63.0
Sex: M
Vaccine: TD
Symptoms: Abdominal pain upper, Diarrhoea, Dizziness
Clinical narrative: Severe stomach cramps, diarrhea, dizziness/lightheaded
Age: 99.0
Sex: F
Vaccine: COVID19, COVID19-2
Symptoms: Asymptomatic COVID-19, Fall, SARS-CoV-2 test positive
Clinical narrative: Patient received moderna vaccine on 2/10/21, 3/10/21, 11/22/21. Presented to ER on 7/21 for a fall.  On 7/27/22, prior to planned discharge, she was found to have a positive COVID-19 test. The facility could not accommodate at that time and she completed her isolation at the hospital. She continued to clinically improve and was found stable for discharge to facility from a medical standpoint on 8/11/22. COVID19 asymptomatic
Age: 99.0
Sex: F
Vaccine: COVID19, COVID19-2
Symptoms: Agonal respiration, Death, Pulse abnormal, Unresponsive to stimuli
Clinical narrative: Patient received moderna vaccine on 2/10/21, 3/10/21, 11/22/21. Presented to ER on 7/21 for a fall.  On 7/27/22, prior to planned discharge, she was found to have a positive COVID-19 test. The facility could not accommodate at that time and she completed her isolation at the hospital. She continued to clinically improve and was found stable for discharge to facility from a medical standpoint on 8/11/22. COVID19 asymptomatic
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: no adverse event, patient received 2nd booster of moderna at age 23 yrs , has asthma, not on steroids
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare  consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working with the Dept of Public Health and Environment on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fall, SARS-CoV-2 test positive
Clinical narrative: Patient received moderna vaccine on 3/13/21, 4/10/21, and 11/22/21. Presented to ER on 8/5/22 due to unwitnessed fall. Found to be COVID positive on 8/2/22. No treatments during this admission for COVID
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 33.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Lymph node pain, Lymphadenopathy, Pain in extremity
Clinical narrative: I wanted to let you know that I had a reaction to the pneumococcal vaccine from when I was in on the 11th. I?m going to try to attach a picture but let me know if it doesn?t go through. My arm is extremely painful (much more painful than it normally is when I get vaccines), it turned very red around the area where the vaccine was given and my lymph nodes in my armpit and breast on the left side are very swollen and hurt badly. I have been taking ibuprofen and I took some Benadryl last night and it seems to be slowly getting better but I wanted you to be aware.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated and one booster.   COVID infection breakthrough
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the local health dept. on a compliance improvement plan and has been reinstated vaccination privileges.